Hikma Pharmaceutical | HIK - الأصول





الأصول تغيير تاريخ
Almirall EUR 2.34B 29.21M 2025-12
argenx SE USD 8.68B 1.51B 2025-12
AstraZeneca USD 114.02B 59M 2026-03
Autolus Therapeutics Ltd USD 527.06M 62M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Fresenius EUR 41.4B 1.07B 2025-12
Genmab DKK 12.87B 5.85B 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
GRIFOLS EUR 20.08B 366M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lakefront Biotherapeutics EUR 3.37B 34.09M 2026-03
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.07B 1.54B 2026-03
Orion EUR 2.08B 69.2M 2026-03
Recordati EUR 5.33B 82.27M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
UCB EUR 18.16B 971M 2025-12